uz
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Kanalga Telegramโ€™da oโ€˜tish

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Ko'proq ko'rsatish

๐Ÿ“ˆ Telegram kanali ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ analitikasi

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 13 291 obunachidan iborat bo'lib, Tibbiyot toifasida 1 940-o'rinni va Saudiya Arabistoni mintaqasida 5 731-o'rinni egallagan.

๐Ÿ“Š Auditoriya koโ€˜rsatkichlari va dinamika

ะฝะตะฒั–ะดะพะผะพ sanasidan buyon loyiha tez oโ€˜sib, 13 291 obunachiga ega boโ€˜ldi.

01 Iyul, 2026 dagi oxirgi maโ€™lumotlarga koโ€˜ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 138 ga, soโ€˜nggi 24 soatda esa -19 ga oโ€˜zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya oโ€˜rtacha 29.30% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 10.12% ini tashkil etuvchi reaksiyalarni toโ€˜playdi.
  • Post qamrovi: Har bir post oโ€˜rtacha 3 896 marta koโ€˜riladi; birinchi sutkada odatda 1 346 ta koโ€˜rish yigโ€˜iladi.
  • Reaksiyalar va oโ€˜zaro taโ€™sir: Auditoriya faol: har bir postga oโ€˜rtacha 37 ta reaksiya keladi.
  • Tematik yoโ€˜nalishlar: Kontent ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ kabi asosiy mavzularga jamlangan.

๐Ÿ“ Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida taโ€™riflaydi:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Yuqori yangilanish chastotasi (oxirgi maโ€™lumot 02 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli boโ€˜lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim taโ€™sir nuqtasiga aylantirishini koโ€˜rsatadi.

13 291
Obunachilar
-1924 soatlar
-277 kunlar
+13830 kunlar
Postlar arxiv
Multidrug-Resistant ุญุฌูŠ ูƒุจูŠุฑ ุจุงู„ุนู…ุฑ ูŠุนุงู†ูŠ ู…ู† ุงู„ุชู‡ุงุจุงุช ููŠ ุงู„ู…ุณุงู„ูƒ ุงู„ุจูˆู„ูŠุฉ ู†ุชูŠุฌุฉ ุงู„ุตุฑู ุบูŠุฑ ุงู„ู…ุจุฑุฑ ูˆ ุงู„ุงุณุชุฎุฏุงู… ุงู„ุฎุงุทุฆ ู„ู„ู…ุถุงุฏุงุช ุง
Multidrug-Resistant ุญุฌูŠ ูƒุจูŠุฑ ุจุงู„ุนู…ุฑ ูŠุนุงู†ูŠ ู…ู† ุงู„ุชู‡ุงุจุงุช ููŠ ุงู„ู…ุณุงู„ูƒ ุงู„ุจูˆู„ูŠุฉ ู†ุชูŠุฌุฉ ุงู„ุตุฑู ุบูŠุฑ ุงู„ู…ุจุฑุฑ ูˆ ุงู„ุงุณุชุฎุฏุงู… ุงู„ุฎุงุทุฆ ู„ู„ู…ุถุงุฏุงุช ุงู„ุญูŠูˆูŠุฉ ู…ู† ู‚ุจู„ ู„ู„ู…ุฑูŠุถ ูƒุงุฑุซุฉ ูˆุงู„ู„ู‡ ุงู„ูˆุญูŠุฏ ุงู„ูŠ ู…ู…ูƒู† ูŠุณุชุฌูŠุจ ุงู„ู‡ ู‡ูˆ Tigecycline

ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุงุญู†ู‡ ุทู„ุงุจ ูƒู„ูŠุฉ ุงู„ุตูŠุฏู„ุฉ _ ุงู„ู…ุฑุญู„ู‡ ุงู„ุฎุงู…ุณู‡ ุนุฏู†ุง ุจุญุซ ุชุฎุฑุฌ ูˆู‡ุฐุง ุงุณุชุจูŠุงู† ูŠุฎุต ุงู„ุจุญุซ ุจู„ุง ุฒุญู…ู‡ ุนู„ูŠูƒู… ุชูƒุฏุฑูˆู† ุชุณุงุนุฏูˆู†ู‡ ุจุฏู‚ูŠู‚ู‡ ู…ู† ูˆู‚ุชูƒู… ูˆุชู…ู„ูˆู† ุงู„ุงุณุชุจูŠุงู† ู‡ุฐุง ูˆุดูƒุฑุงู‹ ู…ู‚ุฏู…ุงู‹ https://docs.google.com/forms/d/e/1FAIpQLScGe57JSan3P32y8GNr4iTXPoVm19cMV6_nE6f33APGEGxTvA/viewform?usp=header ุงู„ุตูุฑ ู„ุง ุชู†ุทุจู‚ ูค- ุชู†ุทุจู‚ ุฌุฏุงู‹ ุงู„ ูกุŒูข- ุชู†ุทุจู‚ ู…ุนุธู… ุงู„ูˆู‚ุช

ุงุฎูˆุงู† ุณุงุนุฏูˆุง ุฒู…ู„ุงุฆูƒู… ุจู…ู„ุฆ ุงู„ุงุณุชุจูŠุงู†ุงุชโ™ฅ๏ธ

- ุงู„ุฑุณุงู„ู‡ ุ› ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุงุญู†ุง ุทู„ุงุจ ุตูŠุฏู„ุฉ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ุนุฏู†ุง ุจุญุซ ูŠู‡ุฏู ุฅู„ู‰ ู…ู‚ุงุฑู†ุฉ ุงู„ุงุซุงุฑ ุงู„ุฌุงู†ุจูŠุฉ ูˆุชุญู…ู„ ุงู„ู…ุฑูŠุถ ู„ู„ู…ูŠุชููˆุฑู…ูŠู† ู…ู‚ุงุจู„ ู…ุซุจุทุงุช DPP4 inhibitors ูŠุง ุฑูŠุช ุชุดุงุฑูƒูˆู†ู‡ ุฑุฆูŠูƒู… ูˆุชู†ุทูˆู†ู‡ ุฌุฒุก ุจุณูŠุท ู…ู† ูˆู‚ุชูƒู… ุชู…ู„ูˆู† ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ๐ŸŒธ https://docs.google.com/forms/d/1EdInAEsPRrpWhN590WCoHnS5CqnFaF0mHuUrsxGOoiA/viewform

Dyslipidemia Arrhythmia Thrombosis ุงู„ู…ูˆุงุถูŠุน ุงู„ู‚ุงุฏู…ุฉ ุฅู† ุดุงุก ุงู„ู„ู‡ ูˆุจุนุฏู‡ุง ุงุฐุง ุงูƒูˆ ูˆู‚ุช ุงุดุฑุญ ูƒู… ู…ูˆุถูˆุน ูˆุงุฐุง ู…ุงูƒูˆ ู ุงุนุชุฐุฑ ุนู† ุงูƒู…ุงู„ ุงู„ุฌุฒุก ุงู„ุจุงู‚ูŠ ู„ุงู† ู„ุงุฒู… ุงุจุฏูŠ ุงุดุฑุญ ุงู„ู…ุงุฏุฉ ุงู„ูˆุฒุงุฑูŠุฉ

ุทู„ุงุจ ุงู„ูŠ ุนู†ุฏู‡ ุดุฑุญ ุฒูŠู† ู„ู„ูƒูŠู…ูŠุงุก ุณุฑูŠุฑูŠุฉ ุฏุฒูˆู‡ู† ุจุงู„ุชุนู„ูŠู‚ุงุช

The first-choice vasopressor in septic shock in patient suffer from tachydysarrhmia is: A. Norepinephrine B. Dobutamine C. Epinephrine D. Phenylephrin

From the previous case. What is the MAP: A) 30 B) 40 C) 50 D) 60 E) None of the above

A previously fit 35-year-old man presents to emergency department with septic shock secondary to arm cellulitis. He is cold peripherally and slightly confused. His HR is 125/min NSR, BP 60/30 mmHg, Respiratory rate 25/min. if his weight is 60 kg, his initial management should be:
A)Start IV fluid 1000 mL in 1 hour B)Start IV fluid 2000 mL in 1 hour C)Start Noradrenaline D)Start Dobutamine E)Start Dopamine

ุงุฎูŠุฑุง๐Ÿ™‚โ€โ†•๏ธ

- ุงู„ุฑุณุงู„ู‡ ุ› ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ู†ุดุชุบู„ ุนู„ู‰ ุจุญุซ ุงู„ุชุฎุฑุฌ ุงู„ุนู†ูˆุงู† ุนู† ุงู†ุชุดุงุฑ ูู‚ุฑ ุงู„ุฏู… ุจูŠู† ุทู„ุงุจ ุงู„ุฌุงู…ุนุงุช ู†ุฑุฌูˆ ู…ู†ูƒู… ุงู„ุชูุถู„ ุจุงู„ู…ุดุงุฑูƒุฉ ููŠ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ูˆุดูƒุฑุง https://docs.google.com/forms/d/e/1FAIpQLSdSudGo_7m3_V1oPehUFuDtkXSDAi4RCXviFm_GlclY4GpNkA/viewform?usp=dialog

- ุงู„ุฑุณุงู„ู‡ ุ› ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ู„ุทูุงู‹ ู…ู…ูƒู† ู…ู„ุฆ ุงู„ุงุณุชุจูŠุงู† ุŒ ุฑุงุฆูŠูƒู… ูŠู‡ู…ู†ุง https://docs.google.com/forms/d/e/1FAIpQLSd2Avx91uJHMJpKelXQDLj4j91SyvK1bIBMdfmC30opZAip6w/viewform?usp=header

ู†ุณุฎุฉ ู…ู† SHOCK.pdf.pdf3.98 MB

- ุงู„ุฑุณุงู„ู‡ ุ› ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ุฏูƒุชูˆุฑ ุงู†ูŠ ุทุงู„ุจุฉ ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ุฏูƒุชูˆุฑ ู†ุญุชุงุฌ ู…ุฑุงูƒุฒ ุชุญู„ูŠู„ูŠุฉ ุงูˆ ู…ูƒุงุชุจ ุงู„ุนู„ู…ูŠุฉ ุงุฐุง ุนุฏู‡ู… ุฃุฌู‡ุฒุฉ ูƒูŠู…ูŠุงุก ุชุญู„ูŠู„ูŠุฉ ู†ุฑูŠุฏ ู„ุจุญุซ ุชุฎุฑุฌู†ู‡ ุงู„ุดุบู„ ุงู„ุนู…ู„ูŠ ู…ุงู„ุชู†ู‡ ุงู†ูˆ ู†ุญู„ู„ ุฌูŠู„ุงุชูŠู† ูƒุจุณูˆู„ ุจุฃุฌู‡ุฒุฉ ุชุญู„ูŠู„ูŠุฉ ุงู„ูŠ ุฑุงุญ ุงุฏุฒู‡ ุงู„ุฌ ู‡ุณู‡ ุญุชู‰ ู†ุนุฑู ู‡ุฐุง ุฌูŠู„ุงุชูŠู† ุญูŠูˆุงู†ูŠ ุงูˆ ู†ุจุงุชูŠ 1. ุงู„ุชุญู„ูŠู„ ุงู„ู†ูˆุนูŠ ู„ู„ู…ูƒูˆู†ุงุช ุงู„ูƒูŠู…ูŠุงุฆูŠุฉ ุฃ. ุงุฎุชุจุงุฑ ุงู„ุฐูˆุจุงู† ุจ. ุงุฎุชุจุงุฑ ุงู„ุจุฑูˆุชูŠู† (ุงุฎุชุจุงุฑ ุงู„ุจูŠูˆุฑูŠุช - Biuret Test) ุฌ. ุงุฎุชุจุงุฑ ุงู„ููŠู†ูˆู„ูุซุงู„ูŠู† 2. ุงู„ุชุญู„ูŠู„ ุงู„ุทูŠููŠ (Spectroscopy Analysis) ุฃ. ุชุญู„ูŠู„ FTIR (ุชุญู„ูŠู„ ุทูŠู ุงู„ุฃุดุนุฉ ุชุญุช ุงู„ุญู…ุฑุงุก) ุจ. ุชุญู„ูŠู„ ุงู„ุฃุดุนุฉ ููˆู‚ ุงู„ุจู†ูุณุฌูŠุฉ UV-Vis 3. ุงู„ุชุญู„ูŠู„ ุงู„ุญุฑุงุฑูŠ (TGA ูˆ DSC) 4. ุงู„ุชุญู„ูŠู„ ุงู„ูƒุฑูˆู…ุงุชูˆุฌุฑุงููŠ (HPLC ูˆ GC-MS) 5. ุงู„ูุญุต ุงู„ู…ุฌู‡ุฑูŠ ุงู„ุฅู„ูƒุชุฑูˆู†ูŠ (SEM-EDX) ุงูˆ ุบูŠุฑู‡ู† ู…ุซู„ุง million test Sudan test